KIT and astrocytoma (excluding glioblastoma): In grade 2–3 astrocytoma, variations in FGFR4, KIT, NTRK2, and positive immunohistochemistry for ATRX and EGFR showed statistically significant results in univariate survival analysis (Figure S2).